Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could ...
UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive treatment called radiofrequency ablation on a comorbid patient with a ...
Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could ...
UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...
Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speedApplication ...
Phase 1a/1b study in 97 patients demonstrates mitochondrial metabolic reprogramming induced by BPM31510-IV and supports advancement in multiple ...
Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in ...
Pancreatic cancer is one of the deadliest malignancies in modern medicine, and its rise has turned quiet daily routines into ...
Can the immune system cure cancer? Dr. Patrick Soon-Shiong discusses a paradigm shift using NK cells to treat tumors without ...
Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...
Pancreatic cancer is one of the deadliest cancers in the world. Each year, about half a million people are diagnosed with it, ...